Advisory Board Members
Dr. Alexey Rak, Director of Bio Structure and Biophysics, Integrated Drug Discovery, Sanofi R&D, France
Dr. Amrik Basran, CSO, Avacta Life Sciences, UK
Dr. Angelito Jonas L. Kalaw, Medical Director, PAREXEL International, Australia
Dr. Anthony W. Coleman, Research Director, University of Lyon, France
Dr. Balázs Sarkadi, Professor, Research Centre for Natural Sciences, Institute of Enzymology, Hungarian Academy of Sciences, Hungary
Dr. David A. Boothman, Professor, Department of Biochemistry, Indiana University, USA
Dr. Emilia Barcia, Professor, University Complutense of Madrid, Spain
Dr. Florian Montel, Head of opnMe.com and CNS Project Leader in Medicinal Chemistry, Boehringer Ingelheim, Germany
Dr. Graham Ball, Professor of Bioinformatics/CSO, Nottingham Trent University/CompanDX, UK
Dr. Laurent Counillon, Professor, University of Nice-Sophia Antipolis, France
Dr. Loui Madakamutil, SVP, Head of Biology and Preclinical Development, Nektar Therapeutics, USA
Dr. Marian Paluch, Professor, University of Silesia, Poland
Dr. Michael Gamlen, Chief Scientific Officer, Gamlen Tableting Ltd., UK
Dr. Minying Cai, Professor, Department of Chemistry & Biochemistry, University of Arizona, USA
Dr. Mahmood Moshiri, President and CEO, Next Pharma Inc., Canada
Dr. Natalie Pankova, Chief Operating Officer, Metadvice Ltd, UK
Dr. Ping Yang, CEO & Chairman, Synbio Technologies LLC, USA
Dr. Shanavaz Nasarabadi, President & Director R&D, GenTegra LLC, USA
Dr. William C. Maier, Chief Scientific Officer & Head, Rare Disease Research, Commercialisation and Outcomes Division, ICON Plc, UK
Dr. Yaakov Naparstek, Chairman of Medicine, Hadassah University Hospital, Israel
Dr. Yukio Yoneda, Invited Professor, Osaka University, Japan
© 2003-2024 All rights reserved by BITeomics |